8-KEarnings & Results

Medtronic plc 8-K Report, Financial Results (Nov 20, 2018)

Filed November 20, 2018For Securities:MDT

Summary

Medtronic plc (MDT) filed an 8-K on November 19, 2018, to report its second quarter fiscal year 2019 financial results, which were announced via press release on November 20, 2018. The primary purpose of this filing is to provide investors with timely access to the company's financial performance for the period. Investors should review the furnished press release (Exhibit 99.1) for detailed financial figures, operational updates, and management's commentary on the company's performance and outlook. This report is crucial for understanding Medtronic's progress in the second quarter of fiscal year 2019, a period critical for assessing the company's strategic execution and its impact on revenue, profitability, and market position. The press release likely contains key metrics such as revenue growth, earnings per share (EPS), and commentary on various business segments, which are essential for investment decisions.

Key Highlights

  • 1Medtronic plc announced its financial results for the second quarter of fiscal year 2019.
  • 2The financial results were disclosed via a press release dated November 20, 2018.
  • 3The press release is furnished as Exhibit 99.1 to the 8-K filing.
  • 4The filing adheres to Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits) of the SEC's Current Report requirements.
  • 5Investors can access the detailed financial performance and commentary within the referenced press release.
  • 6The report covers the period ending in November 2018, providing a snapshot of the company's performance during that time.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally report Medtronic's financial results for the second quarter of fiscal year 2019, as announced in their press release dated November 20, 2018. This makes the financial information readily available to investors and the public.

The detailed financial results, including revenue, earnings, and any commentary from management, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

This report covers Medtronic's financial performance for its second quarter of fiscal year 2019.

This specific 8-K filing primarily serves to report financial results. Any significant business initiatives or strategic updates would typically be detailed within the accompanying press release (Exhibit 99.1) or in subsequent filings. Investors should review the press release for operational commentary.